134 results
Page 3 of 7
8-K
EX-99.1
erl0rb6 gcu
9 Nov 21
Intra-cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update
7:49am
8-K
EX-99.1
9m2pj2x gshsl7xey
9 Aug 21
Intra-cellular Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update
7:37am
8-K
EX-99.1
y3a0qqyo
10 May 21
Intra-cellular Therapies Reports First Quarter 2021 Financial Results and Provides Corporate Update
7:37am
8-K
EX-99.1
ryno1
3 May 21
Intra-Cellular Therapies Announces FDA Acceptance of CAPLYTA® (lumateperone) sNDAs for the Treatment of Bipolar Depression
7:42am
PRE 14A
rkjsnun24xh19
19 Apr 21
Preliminary proxy
5:28pm
8-K
EX-99.1
rplu4w1ukv69o7l
25 Feb 21
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2020 Financial Results and Provides Corporate Update
7:54am
8-K
EX-99.1
u83 hurghl
22 Feb 21
Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression
8:09am
8-K
EX-99.1
bgy0e 165
9 Nov 20
Intra-cellular Therapies Reports Third Quarter 2020 Financial Results and Provides Corporate Update
7:40am
424B5
ztf9ca6ru3uoe z3729
11 Sep 20
Prospectus supplement for primary offering
4:44pm
424B5
a8j2usmu
9 Sep 20
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
8r865nl24 inmzet7
10 Aug 20
Intra-cellular Therapies Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:52am